Mode
Text Size
Log in / Sign up

Dilated Cardiomyopathy

Part of Cardiomyopathy

7 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Dilated Cardiomyopathy

9 trials tracked for Dilated Cardiomyopathy: 2 in phase 3 or 4.

9Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 5 Phase 1 1 Other / NA 1
  1. Phase 4 Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy Completed
  2. Phase 3 PUFAs and Left Ventricular Function in Heart Failure Completed
  3. Phase 2 Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure Completed
  4. Phase 2 Pilot Study of COR-1 in Heart Failure Completed
  5. Phase 2 v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491 Completed
  6. Phase 2 Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy Completed
Show 3 more trials
  1. Phase 2 Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Completed
  2. Phase 1 Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy Completed
  3. N/A ACC - Atrial Contribution to CRT Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cardiomyopathy

Related studies from across the Cardiomyopathy family.

Supraventricular tachyarrhythmias occur more frequently in patients with Arrhythmogenic Cardiomyopathy and Brugada Syndrome
Cardiology Meta-analysis
Supraventricular tachyarrhythmias occur more frequently in patients with Arrhythmogenic Cardiomyopathy and Brugada Syndrome Heart conditions like Brugada syndrome increase risk of rapid heartbeats
This systematic review of 30 studies indicates that supraventricular tachyarrhythmias (SVT) are more frequent in patients with Arrhythmogeni…
Patients with certain heart conditions face a higher risk of fast heartbeats, which can lead to complications like heart failure or unnecess…
Exercise improves cardiorespiratory fitness and quality of life in patients with hypertrophic cardiomyopathy
Physical Medicine & Rehab Meta-analysis
Exercise improves cardiorespiratory fitness and quality of life in patients with hypertrophic cardiomyopathy Exercise improves heart health and fitness for HCM patients
This meta-analysis of 9,702 patients with hypertrophic cardiomyopathy (HCM) found that exercise is associated with increased peak oxygen con…
New research shows that structured exercise can improve heart fitness, body weight, and quality of life for people with hypertrophic cardiom…
Global Longitudinal Strain as a Potential Predictor of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Radiology & Imaging Meta-analysis
Global Longitudinal Strain as a Potential Predictor of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Heart imaging helps identify high risk in cardiomyopathy patients
Meta-analysis suggests reduced global longitudinal strain identifies high-risk patients with hypertrophic cardiomyopathy prone to fatal arrh…
A new way to measure heart muscle movement may help doctors identify which patients with a specific heart condition are at higher risk for s…
Vascular smooth muscle cell immune interactions drive remodeling across cardiovascular diseases
Oncology Sys. Review
Vascular smooth muscle cell immune interactions drive remodeling across cardiovascular diseases How blood vessel cells drive heart disease and high blood pressure
This narrative review synthesizes mechanisms of VSMC-immune interactions in atherosclerosis, hypertension, aortic aneurysms, and arteritis. …
A new review reveals how blood vessel cells change in heart disease, high blood pressure, and more.
Review of Diabetic Cardiomyopathy without reported trial data or specific outcomes
Cardiology Sys. Review
Review of Diabetic Cardiomyopathy without reported trial data or specific outcomes Review of Diabetic Cardiomyopathy offers new understanding of this heart condition
This narrative review addresses Diabetic cardiomyopathy but reports no specific population, sample size, or intervention details. The author…
This review looks at diabetic cardiomyopathy to help doctors understand this specific heart problem better for patients with diabetes.
Mini review examines sudden cardiac death risks in marathon runners across different age groups
Cardiology Sys. Review
Mini review examines sudden cardiac death risks in marathon runners across different age groups Marathon running links to higher heart risk in older men and full-distance participants
This mini review synthesizes evidence on sudden cardiac death (SCD) and coronary artery disease in marathon runners. The authors note that r…
A review of marathon runners shows heart risks vary by age, sex, and race distance, with most events happening near the finish.
Narrative review discusses Ganoderma lucidum polysaccharides for diabetes and related complications
Diabetes & Endocrinology Sys. Review
Narrative review discusses Ganoderma lucidum polysaccharides for diabetes and related complications New research shows mushroom compounds may help control blood sugar and fix organ damage
This narrative review examines the theoretical potential of Ganoderma lucidum polysaccharides (GLPs) for diabetes and associated conditions.
A common mushroom extract could help lower blood sugar and heal organ damage for millions of people with diabetes
Deep learning model screens for transthyretin amyloid cardiomyopathy using ECG images
Cardiology Cohort
Deep learning model screens for transthyretin amyloid cardiomyopathy using ECG images AI spots hidden heart disease from routine ECGs
This observational study developed a deep learning model to identify transthyretin amyloid cardiomyopathy from ECG images.
A new AI tool finds signs of a dangerous heart disease in routine ECGs years before symptoms worsen, offering hope for earlier treatment in …
Systematic review and meta-analysis of MYH7 versus MYBPC3 variants in obstructive hypertrophic cardiomyopathy
Cardiology Meta-analysis
Systematic review and meta-analysis of MYH7 versus MYBPC3 variants in obstructive hypertrophic cardiomyopathy Specific heart genes predict different risks for HCM patients
This systematic review and meta-analysis pooled data from 192,361 participants in cohort or registry studies to compare MYH7 and MYBPC3 vari…
New data shows specific heart genes predict different risks for people with obstructive hypertrophic cardiomyopathy and guide care plans.
Acoramidis associated with lower diuretic intensification in transthyretin amyloid cardiomyopathy
Cardiology Cohort
Acoramidis associated with lower diuretic intensification in transthyretin amyloid cardiomyopathy New Heart Drug Shows Lower Risk of Hospitalization vs Older Option
In this retrospective cohort study using US claims data, acoramidis was associated with a lower risk of diuretic intensification and a compo…
A new heart drug cut diuretic needs and hospitalizations more than the older option in early real-world use.
Thyroid dysfunction and atrial fibrillation risk in hypertrophic obstructive cardiomyopathy patients
Diabetes & Endocrinology Cohort
Thyroid dysfunction and atrial fibrillation risk in hypertrophic obstructive cardiomyopathy patients Thyroid Levels May Predict Heart Rhythm Problems in a Common Heart Condition
This observational cohort study of 755 HOCM patients examined the association between thyroid dysfunction and atrial fibrillation risk.
Monitoring thyroid function could become a simple way to help identify and manage heart rhythm risks in patients with a specific heart muscl…
Review of Visual Standardized Quantification for LGE in Cardiomyopathy
Cardiology
Review of Visual Standardized Quantification for LGE in Cardiomyopathy A new tool improves accuracy and speed for spotting heart risks in patients with cardiomyopathy
This narrative review synthesizes evidence on Visual Standardized Quantification of LGE (VISTAQ) versus conventional techniques.
A new imaging method showed better accuracy and faster analysis times for predicting heart events in patients with specific heart diseases.

Questions about Dilated Cardiomyopathy

Are there specific plasma proteins linked to the severity of Dilated Cardiomyopathy in certain gene carriers?

Yes, plasma proteins like NT-proBNP, GDF-15, FGF-23, ADM, and NCAM1 are linked to dilated cardiomyopathy severity in certain gene carriers, particularly those with TTN or MYBPC3 variants.

Full answer →
How does mainstreaming cardiac genetic testing affect wait times and decision making for Dilated Cardiomyopathy?

Mainstreaming cardiac genetic testing for dilated cardiomyopathy increases testing uptake and reduces wait times, but lowers informed decision-making compared to traditional genetic counseling.

Full answer →
What genetic insights and imaging traits are potential treatment targets for Dilated Cardiomyopathy?

Genetic variants in TTN and TNNT2, plus CMR traits like ventricular dilation and impaired strain, are potential treatment targets for DCM.

Full answer →